Bailard’s Pediatrix Medical MD Stock Holding History

Bailard’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$908K	Hold	35,300	–	–	0.02%	373
2026 Q2	$894K	Hold	35,300	–	–	0.02%	395
2026 Q1	$755K	Buy	35,300 +2,800	+9%	+$58.3K	0.02%	395
2025 Q4	$695K	Sell	32,500 -9,700	-23%	-$199K	0.02%	406
2025 Q3	$707K	Buy	+42,200	New	+$632K	0.02%	414
2025 Q2	–	Sell	-43,300	Closed	-$627K	–	808
2025 Q1	$627K	Buy	43,300 +31,000	+252%	+$440K	0.02%	412
2024 Q4	$161K	Buy	+12,300	New	+$170K	﹤0.01%	702
2020 Q4	–	Sell	-19,900	Closed	-$324K	–	658
2020 Q3	$324K	Buy	+19,900	New	+$370K	0.02%	373
2020 Q1	–	Sell	-15,550	Closed	-$432K	–	529
2019 Q4	$432K	Sell	15,550 -1,500	-9%	-$37.6K	0.02%	323
2019 Q3	$386K	Buy	17,050 +1,400	+9%	+$31.9K	0.02%	338
2019 Q2	$395K	Buy	+15,650	New	+$420K	0.02%	347
2019 Q1	–	Sell	-9,762	Closed	-$322K	–	571
2018 Q4	$322K	Buy	+9,762	New	+$392K	0.02%	406

Other funds holding MD

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Bailard's MD Position: Q3 2026 in Review

Bailard held its Pediatrix Medical (MD) position steady in Q3 2026 at 35,300 shares worth $908K. The position accounts for 0.02% of the portfolio, ranked #373.

Bailard first reported a position in MD in Q4 2018 and has held it in 12 quarters since. 31 funds tracked by Wall St. Rank hold MD as of Q3 2026.

Bailard held 35,300 shares of Pediatrix Medical worth $908K as of Q3 2026.
Bailard left its Pediatrix Medical share count unchanged in Q3 2026.
Pediatrix Medical made up 0.02% of Bailard's portfolio in Q3 2026, its #373 holding.
Bailard first reported a position in Pediatrix Medical in Q4 2018 and has held it in 12 quarters since.
31 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.